These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 16952675

  • 1. Effects of acute treatment with tamsulosin versus alfuzosin on ejaculatory function in normal volunteers.
    Hellstrom WJ, Sikka SC.
    J Urol; 2006 Oct; 176(4 Pt 1):1529-33. PubMed ID: 16952675
    [Abstract] [Full Text] [Related]

  • 2. Effects of alfuzosin and tamsulosin on sperm parameters in healthy men: results of a short-term, randomized, double-blind, placebo-controlled, crossover study.
    Hellstrom WJ, Sikka SC.
    J Androl; 2009 Oct; 30(4):469-74. PubMed ID: 19201696
    [Abstract] [Full Text] [Related]

  • 3. Impact of medical treatments for benign prostatic hyperplasia on sexual function.
    Giuliano F.
    BJU Int; 2006 Apr; 97 Suppl 2():34-8; discussion 44-5. PubMed ID: 16507052
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia.
    Nordling J.
    BJU Int; 2005 May; 95(7):1006-12. PubMed ID: 15839922
    [Abstract] [Full Text] [Related]

  • 5. Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.
    Rosen R, Seftel A, Roehrborn CG.
    Int J Impot Res; 2007 May; 19(5):480-5. PubMed ID: 17717526
    [Abstract] [Full Text] [Related]

  • 6. The beneficial effect of alfuzosin 10 mg once daily in 'real-life' practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation.
    Nickel JC, Elhilali M, Emberton M, Vallancien G, Alf-One Study Group.
    BJU Int; 2006 Jun; 97(6):1242-6. PubMed ID: 16686719
    [Abstract] [Full Text] [Related]

  • 7. Recovery of abnormal ejaculation by intermittent tamsulosin treatment.
    Goktas S, Kibar Y, Kilic S, Topac H, Coban H, Seckin B.
    J Urol; 2006 Feb; 175(2):650-2; discussion 652-3. PubMed ID: 16407016
    [Abstract] [Full Text] [Related]

  • 8. Comparison between tamsulosin and alfuzosin on the expulsion phase of ejaculation in rats.
    Giuliano FA, Clément P, Denys P, Alexandre L, Bernabé J.
    BJU Int; 2006 Oct; 98(4):876-9. PubMed ID: 16879438
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the cardiovascular effects of tamsulosin oral controlled absorption system (OCAS) and alfuzosin prolonged release (XL).
    Michel MC, Chapple CR.
    Eur Urol; 2006 Mar; 49(3):501-8; discussion 508-9. PubMed ID: 16442211
    [Abstract] [Full Text] [Related]

  • 10. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
    Roehrborn CG.
    BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays.
    Tambaro S, Ruiu S, Dessi C, Mongeau R, Marchese G, Pani L.
    J Pharmacol Exp Ther; 2005 Feb; 312(2):710-7. PubMed ID: 15470085
    [Abstract] [Full Text] [Related]

  • 12. Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction.
    van Moorselaar RJ, Hartung R, Emberton M, Harving N, Matzkin H, Elhilali M, Alcaraz A, Vallancien G, ALF-ONE Study Group.
    BJU Int; 2005 Mar; 95(4):603-8. PubMed ID: 15705088
    [Abstract] [Full Text] [Related]

  • 13. The vasodilatory effect of alfuzosin and tamsulosin in passive orthostasis: a randomised, double-blind, placebo-controlled study.
    Nieminen T, Ylitalo R, Kööbi T, Ylitalo P, Kähönen M.
    Eur Urol; 2005 Mar; 47(3):340-5. PubMed ID: 15716198
    [Abstract] [Full Text] [Related]

  • 14. Ejaculatory disorders caused by alpha-1 blockers for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: comparison of naftopidil and tamsulosin in a randomized multicenter study.
    Masumori N, Tsukamoto T, Iwasawa A, Furuya R, Sonoda T, Mori M, Hokkaido Urological Disorders Conference Writing Group.
    Urol Int; 2009 Mar; 83(1):49-54. PubMed ID: 19641359
    [Abstract] [Full Text] [Related]

  • 15. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
    Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Morrill B, Montorsi F, CombAT Study Group.
    J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
    [Abstract] [Full Text] [Related]

  • 16. Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones.
    Agrawal M, Gupta M, Gupta A, Agrawal A, Sarkari A, Lavania P.
    Urology; 2009 Apr; 73(4):706-9. PubMed ID: 19193417
    [Abstract] [Full Text] [Related]

  • 17. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA, Hargreave TB, Roehrborn CG, Alfaur study group.
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy and safety of alfuzosin 10 mg once daily: a 2-year experience in 'real-life' practice.
    Elhilali M, Emberton M, Matzkin H, van Moorselaar RJ, Hartung R, Harving N, Alcaraz A, Vallancien G, ALF-ONE Study Group.
    BJU Int; 2006 Mar; 97(3):513-9. PubMed ID: 16469018
    [Abstract] [Full Text] [Related]

  • 19. "Ejaculatory disorders and alpha1-adrenoceptor antagonists therapy: clinical and experimental researches".
    Grasso M, Fortuna F, Lania C, Blanco S.
    J Transl Med; 2006 Jul 14; 4():31. PubMed ID: 16842616
    [Abstract] [Full Text] [Related]

  • 20. Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission.
    Hisasue S, Furuya R, Itoh N, Kobayashi K, Furuya S, Tsukamoto T.
    Int J Urol; 2006 Oct 14; 13(10):1311-6. PubMed ID: 17010010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.